Regulation and functional consequences of mGlu₄ RNA editing

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Metabotropic glutamate receptor 4 (mGlu4) is a Class C G protein-coupled receptor crucial for neurotransmitter release.
• mGlu4 is implicated in various neurological disorders, making it a significant drug target.
• Understanding mGlu4 regulation and pharmacology is essential for therapeutic development.

Purpose of the Study:

• To validate and quantify RNA editing events in mGlu4 mRNA, specifically the adenosine-to-inosine (A-to-I) conversion at glutamine 124 (Q124R).
• To investigate the functional consequences of mGlu4 RNA editing on receptor dimerization and G protein activation.
• To explore the conservation and regulatory factors of mGlu4 RNA editing across mammalian species.

Main Methods:

• High-throughput sequencing to identify and quantify RNA editing events.
• In vitro RNA editing assays to validate pre-mRNA duplexes and ADAR enzyme activity.
• Structural modeling to predict the impact of amino acid substitutions on receptor structure.
• Cell-based assays to measure G protein activation and heterodimerization propensity.

Main Results:

• Validated an A-to-I RNA editing event converting mGlu4 Q124R and identified a novel K129R site.
• Demonstrated that the Q124R substitution occurs in a critical region for receptor dimerization.
• Showed that while homodimer G protein activation is unaffected, mGlu4 Q124R exhibits reduced heterodimerization with mGlu2 and mGlu7.

Conclusions:

• This study provides the first extensive description of mGlu4 mRNA editing extent and regulation.
• The Q124R editing event functionally impacts mGlu4 heterodimerization, suggesting a novel mechanism for regulating receptor activity in vivo.
• Findings expand the understanding of mGlu receptor regulatory capacity and offer new perspectives for drug development targeting mGlu4.